home / stock / vtrs / vtrs news


VTRS News and Press, Viatris Inc.

Stock Information

Company Name: Viatris Inc.
Stock Symbol: VTRS
Market: NASDAQ

Menu

VTRS VTRS Quote VTRS Short VTRS News VTRS Articles VTRS Message Board
Get VTRS Alerts

News, Short Squeeze, Breakout and More Instantly...

VTRS - SOUN, LI, RDFN, VTRS, BENF showing five-day downward plunge

2024-05-17 10:47:03 ET SoundHound AI Inc. (SOUN) SOUN is trading DOWN for the last 4 days, and it at trading at $5.08 with volume of 17,289,089 and a one day change of $-0.13 (-2.50%). SoundHound AI Inc. has a 52-week low of 1.00 and a 52-week high of $5.11. The business's 50-day mo...

VTRS - Regeneron wins temporary restraining order preventing Eylea generics

2024-05-17 10:01:34 ET More on Regeneron Pharmaceuticals Regeneron Pharmaceuticals Inc (REGN) RBC Capital Markets Global Healthcare Conference (Transcript) Regeneron: Dissecting The First Quarter Results And Regulatory Setbacks Regeneron Pharmaceuticals, Inc. (REGN) ...

VTRS - Larry Robbins' Glenview Capital takes in Broadcom, exits Intel among Q1 moves

2024-05-16 11:01:24 ET Billionaire Larry Robbins' Glenview Capital Management took a stake in Broadcom ( NASDAQ: AVGO ), exited its position in Intel ( NASDAQ: INTC ), and substantially added to holdings in health insurers in Q1 2024, among other changes.... Read the f...

VTRS - Viatris Inc. (VTRS) BofA Securities 2024 Health Care Conference (Transcript)

2024-05-14 19:18:07 ET Viatris Inc. (VTRS) BofA Securities 2024 Health Care Conference May 14, 2024, 01:00 PM ET Company Participants Doretta Mistras - Chief Financial Officer Philippe Martin - Chief R&D Officer Conference Call Participants Jason Gerb...

VTRS - Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio - Q1 2024 Update

2024-05-13 22:19:41 ET Summary Davis Selected Advisers' 13F portfolio value increased to $17.84B, with a decrease in the number of holdings from 103 to 98. The top three holdings in the portfolio are Berkshire Hathaway, Meta Platforms, and Capital One Financial. Stake increase...

VTRS - 8 out of 12 S&P 500 healthcare companies beat profit consensus this week: Earnings Scorecard

2024-05-12 11:22:00 ET This week, the healthcare sector saw 12 companies reporting their quarterly earnings, with 8 of them beating their bottom-line numbers for the quarter.... Read the full article on Seeking Alpha For further details see: 8 out of 12 S&P 500 healthcar...

VTRS - Organon Graduates From Spinoff Skepticism, With A Yield Above 5%

2024-05-11 06:58:33 ET Summary Organon, Pfizer, and Bristol Myers all offer yields above 5% and can  compete with most Treasuries, but only Organon is up YTD. Spinoffs often struggle in their initial years, but Organon's partial reversal of its decline since Merck's castoff h...

VTRS - About 70% of S&P 500 names beat EPS, while 47% soar past revenue estimates this week - Earnings Scorecard

2024-05-10 12:55:34 ET As first-quarter earnings continue to march on, here is a recap of a few big names that posted their quarterly results, along with their respective commentaries about the future.... Read the full article on Seeking Alpha For further details see: A...

VTRS - Viatris Inc. (VTRS) Q1 2024 Earnings Call Transcript

2024-05-09 12:00:10 ET Viatris Inc. (VTRS) Q1 2024 Earnings Call Transcript May 09, 2024, 08:30 AM ET Company Participants Bill Szablewski - Head of Capital Markets Scott Smith - CEO Philippe Martin - Chief R&D Officer Doretta Mistras - CFO Conferen...

VTRS - Teva Pharmaceutical: 6 Takeaways From Q1 2024 Earnings Results

2024-05-09 08:15:00 ET Summary Teva Pharmaceutical stock has been trending higher since October 2023, closing at nearly $16.00. The company reported strong first-quarter results, with increased revenue and growth in key metrics. Teva has a positive business outlook for 2024, w...

Next 10